@et565 @Dermpathl Look, still low net benefit of even this test. The problem of closed data and limited controls compounds itself https://t.co/E9A7uaSknB I don’t know OncotypeDx apparently as well as you but it’s also not my standard for cSCC. You know t
2,451 followers
1,346 followers
RT @JNCI_Now: Costs of Oncotype DX-concordant systemic breast cancer therapy based on the TAILORx Trial #bcsm https://t.co/INVe5BdVx2 http…
1,550 followers
RT @JNCI_Now: Costs of Oncotype DX-concordant systemic breast cancer therapy based on the TAILORx Trial #bcsm https://t.co/INVe5BdVx2 http…
434 followers
RT @jdflaysakier: Un test qui évite des chimios inutiles pour la forme la plus fréquente de cancer du sein. Accepté dans des dizaines de pa…